IVS Stock Overview
A private equity firm specializing in mature, middle market, buyouts and growth capital investments. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Investor AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 25.28 |
52 Week High | SEK 28.15 |
52 Week Low | SEK 18.49 |
Beta | 0.76 |
11 Month Change | -4.35% |
3 Month Change | -4.42% |
1 Year Change | 36.06% |
33 Year Change | 18.96% |
5 Year Change | 115.24% |
Change since IPO | 1,250.82% |
Recent News & Updates
Recent updates
Shareholder Returns
IVS | DE Diversified Financial | DE Market | |
---|---|---|---|
7D | -1.1% | -0.7% | 0.2% |
1Y | 36.1% | 4.8% | 8.5% |
Return vs Industry: IVS exceeded the German Diversified Financial industry which returned 4.8% over the past year.
Return vs Market: IVS exceeded the German Market which returned 8.5% over the past year.
Price Volatility
IVS volatility | |
---|---|
IVS Average Weekly Movement | 3.3% |
Diversified Financial Industry Average Movement | 3.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: IVS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: IVS's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1916 | 18,795 | Christian Cederholm | www.investorab.com |
Investor AB (publ) is a private equity firm specializing in mature, middle market, buyouts and growth capital investments. For core investments, the firm invests in health care, financial services, IT and fintech sectors and considers investments in listed companies in leading minority positions. The firm seeks to invest globally.
Investor AB (publ) Fundamentals Summary
IVS fundamental statistics | |
---|---|
Market cap | €79.24b |
Earnings (TTM) | €17.82b |
Revenue (TTM) | €23.05b |
4.4x
P/E Ratio3.4x
P/S RatioIs IVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IVS income statement (TTM) | |
---|---|
Revenue | SEK 265.08b |
Cost of Revenue | SEK 32.77b |
Gross Profit | SEK 232.31b |
Other Expenses | SEK 27.33b |
Earnings | SEK 204.98b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 23, 2025
Earnings per share (EPS) | 66.92 |
Gross Margin | 87.64% |
Net Profit Margin | 77.33% |
Debt/Equity Ratio | 11.2% |
How did IVS perform over the long term?
See historical performance and comparison